Prelude Capital Management, LLC Fulcrum Therapeutics, Inc. Transaction History
Prelude Capital Management, LLC
- $1.12 Billion
- Q3 2025
A detailed history of Prelude Capital Management, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 28,832 shares of FULC stock, worth $249,973. This represents 0.02% of its overall portfolio holdings.
Number of Shares
28,832
Previous 143,129
79.86%
Holding current value
$249,973
Previous $984,000
74.49%
% of portfolio
0.02%
Previous 0.11%
Shares
9 transactions
Others Institutions Holding FULC
# of Institutions
133Shares Held
55.4MCall Options Held
176KPut Options Held
13.5K-
Ra Capital Management, L.P. Boston, MA10.2MShares$88.7 Million1.53% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.38MShares$46.7 Million1.41% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$45.5 Million5.13% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$41.6 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.67MShares$40.5 Million1.65% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $451M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...